Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells

Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells

ME (Emmy) M Dolman1, Stefan Harmsen1, Ebel HE Pieters1, Rolf W Sparidans2, Marie Lacombe3, B&aacute;lint Szokol4, L&aacute;szl&oacute; Orfi4, Gy&ouml;rgy K&eacute;ri4, Gert Storm1, Wim E Hennink1, Robbert J Kok11Department of Pharmaceutics, Utrecht Institute f...

Full description

Bibliographic Details
Main Authors:	Dolman MEM, Harmsen S, Pieters EHE, Sparidans RW, Lacombe M, Szokol B, Őrfi L, K&eacute;ri G, Storm G, Hennink WE, Kok RJ
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-01-01
Series:	International Journal of Nanomedicine
Online Access:	http://www.dovepress.com/targeting-of-a-platinum-bound-sunitinib-analog-to-renal-proximal-tubul-a9156

Similar Items

Visualization of gold and platinum nanoparticles interacting with Salmonella Enteritidis and Listeria monocytogenes
by: Ewa Sawosz, et al.
Published: (2010-08-01)

Corrosion due to ageing influences the performance of tubular platinum microrobots
by: Maric, Tijana, et al.
Published: (2019)

Acute sunitinib neurotoxicity
by: Ahmet GULMEZ, et al.
Published: (2021-01-01)

Preparation of platinum-free tubular dye-sensitized solar cells by electrophoretic deposition
by: Khwanchit Wongcharee, et al.
Published: (2016-10-01)

Sunitinib in pancreatic neuroendocrine tumors. Clinical case
by: A. A. Markovich, et al.
Published: (2019-12-01)

Potential for use sunitinib in pancreatic neuroendocrine tumors
by: A. A. Markovich, et al.
Published: (2019-06-01)

Sunitinib for advanced renal cell cancer
by: Chris Coppin
Published: (2008-03-01)

Sunitinib resistance in renal cell carcinoma
by: Christudas Morais
Published: (2014-04-01)

Sorafenib and sunitinib: A dermatologist′s perspective
by: Vijendran Pragasam, et al.
Published: (2014-01-01)

The role of sunitinib in the therapy of metastatic renal cell carcinoma
by: I. G. Rusakov, et al.
Published: (2020-07-01)

Manifestações dermatológicas do maleato de sunitinibe
by: Fernanda Silveira Fernanda
Published: (2013-11-01)

Sunitinib in the treatment of metastatic renal cell carcinoma
by: Thomas A. Schmid, et al.
Published: (2016-12-01)

MANIFESTAÇÕES DERMATOLÓGICAS DO MALEATO DE SUNITINIBE
by: Carolina Degen Meotti, et al.
Published: (2014-07-01)

Sunitinib induced pyoderma gangrenosum-like ulcerations
by: Akanay-Diesel S, et al.
Published: (2011-11-01)

Impact of Sunitinib on Human Thyroid Cancer Cells
by: Jirka Grosse, et al.
Published: (2013-07-01)

Efficacy and safety analysis of TACE + sunitinib vs. sunitinib in the treatment of unresectable advanced renal cell carcinoma: a retrospective study
by: Haohao Lu, et al.
Published: (2023-03-01)

The Effect of Sunitinib Treatment in Human Melanoma Xenografts: Associations with Angiogenic Profiles
by: Jon-Vidar Gaustad, et al.
Published: (2017-04-01)

Bis[bis(diphenylthiophosphinyl)amido-&#954;2S,S&#8242;]platinum(II)
by: Cemal G&#252;zelsoylu, et al.
Published: (2011-04-01)

Sunitinib for adenocarcinoma of the rete testis: a case report
by: Kezhen Li, et al.
Published: (2024-04-01)

Key sunitinib‐related biomarkers for renal cell carcinoma
by: Yun Peng, et al.
Published: (2021-10-01)

Experience with sunitinib in the treatment of metastatic renal cell carcinoma
by: Manuela Schmidinger, et al.
Published: (2012-10-01)

Metastatic collecting duct carcinoma of the kidney treated with sunitinib
by: M'rabti Hind, et al.
Published: (2011-07-01)

Platinum nanoparticles: an exquisite tool to overcome radioresistance
by: Sha Li, et al.
Published: (2017-07-01)

Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study
by: Bibian M. E. Tullemans, et al.
Published: (2022-06-01)

Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases.
by: Charles C L Tong, et al.
Published: (2012-01-01)

In vivo effects of sirolimus and sunitinib of breast cancer prognostic markers
by: Jaffar, Nurul Fathiyatul Nabila
Published: (2020)

Sunitinib potentiates the cytotoxic effect of electrochemotherapy in pancreatic carcinoma cells
by: Bosnjak Masa, et al.
Published: (2022-03-01)

Sunitinib efficacy with minimal toxicity in patient-derived retinoblastoma organoids
by: Atthapol Srimongkol, et al.
Published: (2023-02-01)

3158 Sunitinib-Induced Cardiotoxicity in an Engineered Cardiac Microtissue Model
by: Carissa Livingston, et al.
Published: (2019-03-01)

Induction of trismus by sunitinib and pazopanib in metastatic renal cell carcinoma
by: Ridhima Iyer, et al.
Published: (2017-01-01)

Renal Soluble Guanylate Cyclase Is Downregulated in Sunitinib‐Induced Hypertension
by: Jeannine Witte, et al.
Published: (2018-09-01)

Safety and Efficacy of Sunitinib in Patients with Unresectable Pancreatic Neuroendocrine Tumors
by: Marcus W. Wiedmann, et al.
Published: (2012-11-01)

Sunitinib in the treatment of renal cell carcinoma: an update on recent evidence
by: Mimma Rizzo, et al.
Published: (2017-08-01)

Retraction: metastatic collecting duct carcinoma of the kidney treated with Sunitinib
by: Tazi El, et al.
Published: (2011-10-01)

Early onset recall pneumonitis during targeted therapy with sunitinib
by: Yuasa Takeshi, et al.
Published: (2013-01-01)

Nephrotic Syndrome and Acute Renal Failure Apparently Induced by Sunitinib
by: Ying-Shou Chen, et al.
Published: (2009-10-01)

Sunitinib-induced localized depigmentation over melasma in an elderly woman
by: Sambasiviah Chidambara Murthy, et al.
Published: (2022-01-01)

Safety and Efficacy of Sunitinib in Patients with Unresectable Pancreatic Neuroendocrine Tumors
by: Marcus W. Wiedmann, et al.
Published: (2012-01-01)

Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib
by: H. Mohammad, et al.
Published: (2022-01-01)

Complete remission of metastatic renal cell carcinoma to the bone with sunitinib
by: Akihiro Yoshimura, et al.
Published: (2020-09-01)